Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas.
about
Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activationIL-21 Signaling in ImmunityInterleukin-21 enhances rituximab activity in a cynomolgus monkey model of B cell depletion and in mouse B cell lymphoma modelsAn overview on the role of dietary phenolics for the treatment of cancersLymphoma: immune evasion strategiesInterleukin-21 promotes thymopoiesis recovery following hematopoietic stem cell transplantation.New developments in the pathology of malignant lymphoma: a review of the literature published from October 2009 to January 2010Efficacy of bortezomib in a direct xenograft model of primary effusion lymphomaBID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy responseRole of common-gamma chain cytokines in NK cell development and function: perspectives for immunotherapy.Antibody-cytokine fusion proteins for treatment of cancer: engineering cytokines for improved efficacy and safety.Interleukin 21 Controls mRNA and MicroRNA Expression in CD40-Activated Chronic Lymphocytic Leukemia CellsIdentification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma.Increased Th17 cells and IL-17A exist in patients with B cell acute lymphoblastic leukemia and promote proliferation and resistance to daunorubicin through activation of Akt signalingChromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathway.A phase I dose-finding trial of recombinant interleukin-21 and rituximab in relapsed and refractory low grade B-cell lymphoproliferative disordersInterleukin-21: a double-edged sword with therapeutic potential.IL-21: a pleiotropic cytokine with potential applications in oncology.Interleukin 21 - its potential role in the therapy of B-cell lymphomas.Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.EBV counteracts IL-21-induced apoptosis in an EBV-positive diffuse large B-cell lymphoma cell line.Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo.Epstein-Barr virus (EBV) provides survival factors to EBV+ diffuse large B-cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+ DLBCL.Cytotoxic Epstein-Barr virus-positive large B cell lymphoma: a regulatory B cell-derived neoplasia?Effect of interleukin 21 and its receptor on CD8(+) T cells in the pathogenesis of diffuse large B-cell lymphoma.Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis.IL-21 promotes CD4 T cell responses by phosphatidylinositol 3-kinase-dependent upregulation of CD86 on B cellsTissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis.Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer.Gene expression analysis of plasmablastic lymphoma identifies downregulation of B-cell receptor signaling and additional unique transcriptional programs.Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus.Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop.Enhancement of CD154/IL4 proliferation by the T follicular helper (Tfh) cytokine, IL21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia.ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements.Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo.
P2860
Q24307782-7A3A56E2-B1E4-44F9-BC36-C5CB28724CC1Q26766361-E13B860A-2F7A-446C-A6DA-BD728F177CFEQ27312250-0101F499-A4C8-4017-BFD9-5D4A34DADCEEQ28071894-11B92D32-5497-4D79-9C9E-8DC5D17EAFF2Q28080705-52875C08-6A5E-4790-B528-53074D7E46D4Q33802076-5BBC14B7-A1BF-4023-B904-76B3A8C4ACD2Q33906881-D081A4E0-C8C7-468B-A3E6-34B20B601E89Q34059058-07387235-1482-42AF-9C45-820EDBE4981CQ34182014-4D7E43CC-2EF1-41D5-9CF9-A72DFC9517DAQ35054508-0E51BB07-F869-4D16-A7EF-00103C129324Q35163167-85F3EA31-3CC4-43E0-B5DE-22A208457E68Q35754594-FF5C07EE-87F1-41DB-AE2F-8887EDE6CCF6Q36015211-B9E8AFA8-F7E8-484A-8B6A-BC398AE9CA4CQ36091283-6CE62F4C-0516-4CCE-BC66-BF202763BB9DQ36898544-B360DEB9-A549-474D-A1F2-487E239CBF93Q36935112-500617BE-1C3F-4640-A578-415F15F2128FQ37265471-BD87905D-08AC-4AEF-AB66-5BCFE0EA1F13Q38206058-D483A3A9-9EF1-496F-946E-1B4076354689Q38471387-14DA9061-751F-4439-A3C1-8B25C8C8057DQ38894228-0E9B1645-0762-40CD-939C-DD558A672283Q38993869-96F3389B-1ECF-4CB1-8E1E-B2C21B4F2ECFQ39201830-CF484E85-4627-441A-A2CB-714BE62DADDFQ39423588-D49B65A0-411A-4440-ACE7-F3AF0EBCBBEEQ40126382-18BAAE30-AF52-4A20-9383-4F3640D834ADQ40484859-00295A45-D709-4129-9F93-D1FE097FC1A5Q40892019-AAB59183-0BD2-474D-A58C-BE4DE2F7D7A5Q41872521-CBCD8FED-4BE3-4769-A7F2-1D0D53B8C9E0Q41973852-3BB3823C-42F5-42EB-B28B-710921CA1DB7Q44679354-9A6038A8-7196-42F2-8AD4-E4CBDFD48A0AQ44909418-DD5F4877-D5C6-4AF5-B8E6-60183EF2A0B4Q45012890-ECA0815F-714D-4E0B-99B9-7E07F7E757BDQ46405400-EEC93904-B93F-4114-8058-3FC9DE82EEBEQ49036164-6377801A-8F95-45A0-B213-521FB8873D7CQ50958025-F94E4B0C-65BF-4628-919A-253FAF8FE7F2Q51061497-8BB083E3-1F10-450E-A43C-28B5145BECB0Q53172958-9A11E48A-FF70-4B03-83A9-BF479FAA20DC
P2860
Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Novel IL-21 signaling pathway ...... iffuse large B-cell lymphomas.
@ast
Novel IL-21 signaling pathway ...... iffuse large B-cell lymphomas.
@en
type
label
Novel IL-21 signaling pathway ...... iffuse large B-cell lymphomas.
@ast
Novel IL-21 signaling pathway ...... iffuse large B-cell lymphomas.
@en
prefLabel
Novel IL-21 signaling pathway ...... iffuse large B-cell lymphomas.
@ast
Novel IL-21 signaling pathway ...... iffuse large B-cell lymphomas.
@en
P2093
P2860
P1433
P1476
Novel IL-21 signaling pathway ...... diffuse large B-cell lymphomas
@en
P2093
Andrew J Gentles
Eli Avisar
Hovav Nechushtan
Izidore S Lossos
Raquel Malumbres
P2860
P304
P356
10.1182/BLOOD-2009-08-239996
P407
P577
2009-11-20T00:00:00Z